KLRK1 and hepatocellular carcinoma: As NKG2D receptors are expressed on CD8+ T cells, NKG2D ligands and ULBP carried by exosomes can inhibit the cytotoxicity of CD8+ T cells through NKG2D receptors and thereby induce HCC immune escape [6, 136].